|
SBI Symposium Collection: Multi-Modality

SBI Symposium Collection: Multi-Modality

The Multi-Modality Symposium Collection is designed to enhance a learner's competence in deciding when multi-modality breast imaging is indicated and how it can aid in differentiating benign from malignant entities. Beyond mammography and ultrasound utilization, learners will be able to describe applications for molecular breast imaging, PET/CT, and a systematic approach to breast MRI interpretation. This collection features presentations from the 2022 SBI Symposium.

 

CE Information

Earn up to 3.5 AMA PRA Category 1 Credits

CME Released:  05/17/2023   CME Expires:  05/31/2026

 

Learning Objectives

  • Describe appropriate and inappropriate use of multi-modality breast imaging.
  • Identify benign and malignant features of internal mammary and axillary lymph nodes.
  • Describe applications of molecular breast imaging.

 

Multi-Modality Lectures 

1. Multimodality Cases I

       Presenters: Karen Johnson, MD, FSBI and Catherine Giess, MD, FSBI

 

2. Multimodality Cases II

       Presenters: Katrina Glazebrook, MD, FSBI and Kathleen Brandt, MD, FSBI

 

3. MBI - Technology, Interpretation, and Integration (with Cases)

       Presenters: Amy Fowler, MD, FSBI; Katie Hunt, MD, FSBI and Carrie Hruska, PhD, FSBI

 

4. MRI Interpretation and Cases

       Presenters: Habib Rahbar, MD, FSBI and Kimberly Ray, MD, FSBI

 

Statement of Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Michigan State Medical Society and the Society of Breast Imaging. The Michigan State Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

 

AMA Credit Designation Statement: The MSMS designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

Multimodality Cases I

Session Description: Interesting and challenging cases that benefit from or require multi-modality breast imaging for accurate diagnosis will be presented. Key teaching points will be highlighted.

Learning Objectives:

  1. Demonstrate applications of multi-modality breast imaging to various challenging clinical and imaging presentations.
  2. Illustrate cases in which multi-modality imaging was needed for accurate diagnosis of breast lesions.
  3. Discuss appropriate and inappropriate use of multi-modality imaging in the workup and evaluation of breast lesions.
Speaker Information
Catherine Giess MD, FSBI
Karen Johnson MD, FSBI
Multimodality Cases II

Session Description: In this session, we will be demonstrating multimodality work up of interesting and unusual benign and malignant processes in the breast, chest wall, axillary and internal mammary lymph nodes. Imaging modalities will include mammography, breast US, MRI, MBI and PET/CT with pathologic and clinical correlation.

Learning Objectives:

  1. Discriminate between benign from malignant internal mammary and axillary adenopathy with more confidence.
  2. Understand the appropriate workup, imaging appearance and treatment for uncommon breast conditions such as fibromatosis of the breast and chest wall and angiosarcoma.
  3. Conduct the appropriate work-up, using multiple modalities, for various breast conditions and understand concordance between different modalities.
Speaker Information
Kathleen Brandt MD, FSBI
Katrina Glazebrook MD, FSBI
MBI - Technology, Interpretation, and Integration (with Cases)

Session Description: This session will provide an overview of current Molecular Breast Imaging (MBI) technology and recent evidence-based updates to use of MBI in clinical practice. Practical expert guidance in MBI technique and case interpretation will be provided. New developments in MBI will be discussed, including direct MBI-guided biopsy capability, further reductions in radiation dose, and breast cancer risk prediction.

Learning Objectives:

  1. Understand how molecular breast imaging is performed and interpreted.
  2. Discuss applications for MBI, including supplemental screening and risk assessment.
  3. Understand the benefits and limitations of MBI.
Speaker Information
Amy Fowler MD, FSBI
Carrie Hruska PhD, FSBI
Katie Hunt MD, FSBI
MRI Interpretation and Cases

Session Description: In this session, we will review a systematic approach to an effective breast MRI interpretation, with focus on how to approach relevant imaging series, use of BI-RADS lexicon, with considerations for emerging technologies such as abbreviated MRI, DWI, and ultrafast MRI. This approach will be augmented by presentation of a range of cases that serve to illustrate this approach to interpretation.

Learning Objectives:

  1. Describe a systematic approach to breast MRI interpretation.
  2. Apply conventional kinetics, ultrafast, and diffusion weighted imaging features to improve interpretation specificity.
  3. Develop management strategies for complex clinical scenarios through analysis of challenging cases.
Speaker Information
Habib Rahbar MD, FSBI
Kimberly Ray MD, FSBI
Individual topic purchase: Selected
Michigan State Medical Society: AMA PRA Category 1 Credit(s)
AMA PRA Category 1 Credit(s)™: 3.50
Preview
Preview Multimodality Cases IPreview Multimodality Cases I
Products
SBI Symposium Collection: Multi-Modality
Member: $199.00
Non-Member Price: $299.00